MTOR and hepatocellular carcinoma: Dysregulation of this cascade enhances proliferation, survival, and invasion, and is closely interconnected with the PI3K/Akt/mTOR and Wnt/β-catenin pathways, promoting both HCC progression and therapy resistance [65].